Bridge Funding Program

Current Cycle Deadline Extended to December 20, 2017

Application materials should be submitted in ONE PDF file via email to Anne Meska at anne.meska@duke.edu

The following outlines a bridge funding plan to help investigators in the School of Medicine who have had a lapse in R0l-or P0l-level support. U-level awards and R21s will not be considered at this time. Up to $100,000 per lapsed R0l grant or up to $200,000 per lapsed P0l grant will be provided by the Dean's Office and the Chair’s Office (combined total) following application by the affected individual's chair, anonymous review of merit by two appropriate referee in the School of Medicine, and a positive recommendation by the Bridge Funding Committee. Although not an eligibility requirement, the level of central funding for each bridge funding award will take into consideration available discretionary balances at the unit/department and individual level.
 

Eligibility

  • Candidates include School of Medicine faculty members who were unsuccessful with a first submission of a competitive renewal of an independent investigator award (NIH R01 or equivalent) or a program project grant.
  •  Applications that were unsuccessful but received a priority score will be most competitive, and the candidate must effectively address the concerns outlined in the summary statement.
  •  Applications for bridge funding of an unsuccessful (Al) resubmission of a competitive renewal will be considered if:
    • the applicant received a strong priority score, and
    • the applicant effectively describes how the summary statement will guide development of a new application.
  • Applications for bridge funding of an unsuccessful first submission of a new R0l proposal will be considered only if:
    •  the new proposal represents replacement funding for a previous R01-level, NIH-funded line of investigation that has run its course within the last 2 years, or
    •  the applicant has completed a K08, K23, K12, or KOl grant or an equivalent NIH K grant intended for transition to independence and has received a priority score on the original ROl submission.
  • Internal K awards are not eligible for bridge awards.
  • An application will not be considered by the Committee if the expired grant to which it linked has already received bridge funds.

Questions regarding eligibility prior to submission of an application can be addressed to Sue Jinks-Robertson at sue.robertson@duke.edu.
 

Mechanism for application

 Applications may be submitted for deadlines of August 15, December 15 and April 15.  Application materials should be submitted via the investigator's department chair and must include:

  •  The chair's letter of endorsement that also commits department resources to pool with institutional bridge funds. The Department is expected to provide $50,000 (or $100,000 for a P01) to match the contribution of the Dean unless a compelling case for a lesser contribution can be made.
  • Recommendations by the chair of at least three faculty members outside the candidate's primary department who can provide an expert and unbiased review of the application.
  • The specific aims page and the summary statement of the unsuccessful application for which bridge funding is requested. In the case of replacement funds for a K-type award or grant that has run its course, the number of the grant being replaced must be provided.
  • The investigator's response to the summary statement of the unsuccessful application
  • The investigator's updated NIH biosketch.
  • Plans for expenditure of the requested bridge funds.
  • A complete summary of other funds available during the bridge period (e.g. discretionary funds, gift accounts, training grants).
  • Plans to secure funds (e.g., other applications, mentoring plan, grant writing course).

Please assemble these components of the application as a single .pdf in the order listed above. 
 

Application review process

  • Assessment of all application materials by two faculty members in the School of Medicine with appropriate expertise and without a departmental affiliation with the candidate, selected with input from the candidate's chair.
  • Preparation of a brief statement by the reviewers describing the merits of the case and the likelihood of external funding following bridge support.
  • Review of the two faculty assessments and all application materials by Bridge Funding Committee.
  • Recommendation by Bridge Funding Committee to the Dean of the School of Medicine.
  • One factor in determining the amount of Dean’s Office support in a successful application is the degree to which the applicant has significant personal discretionary funds are available.
  • Departments with available reserve balances are expected to match the Dean’s Office funding for each application.

Medicine

  • One factor in determining the amount of Dean’s Office support in a successful application is the degree to which the applicant has significant personal discretionary funds are available.
  • Departments with available reserve balances are expected to match the Dean’s Office funding for each application.